Effects of Instrument Assisted Soft Tissue Mobilization Regarding Range of Motion and Lower Extremity Power

NCT ID: NCT06610058

Last Updated: 2024-09-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-08

Study Completion Date

2024-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are:

* Does IASTM treatment have an effect on range of motion (ROM) as measured in the hip, knee and ankle?
* Does IASTM treatment have an effect on lower extremity power? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change range of motion and/or lower extremity power.

Participants will:

* Complete a questionnaire on medical history and injury background
* Have hip, knee and ankle range of motion (ROM) measurements taken on both lower extremities using a goniometer
* Complete three trials of vertical jump testing using a Fleage Floor standing vertical jump measurement tester with one warm up first
* Complete three trials of horizontal jump testing using a Woanger 12'x2.5' long jump mat and verified by a secondary measure using a tape measure with one warm up first
* Be randomly assigned to either IASTM first treatment group or the wait/control first group
* Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the hamstrings, quadriceps, gastroc/soleus complex, and Achilles tendon using the HG8-Scanner tool for 15 strokes in each direction. Then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction.
* Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when completing the control treatment.
* Complete hip, knee and ankle range of motion and vertical and horizontal jump measure testing at the end of the first session.
* Return within fourteen days after the first session in order to undergo the opposite experience (IASTM first means wait/control second and vice versa).
* Undergo the same baseline pre-test measurements for range of motion and vertical and horizontal jump measure testing as the first session.
* Experience the opposite treatment for the same time period as the first session.
* Undergo the post-test range of motion and vertical and horizontal jump measure testing at the end of the second session for data comparison.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

No further information to note than what is described in the summary or elsewhere

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IASTM First

This arm of the study received IASTM treatment on the first day and the wait/control on the second day of the study

Group Type EXPERIMENTAL

Instrument Assisted Soft Tissue Mobilization first Control second

Intervention Type OTHER

Instrument assisted soft tissue mobilization was utilized first on day one and wait-control was completed on second day.

Wait/control First

This arm of the study waited (was the control) on the first day and received IASTM treatment on the second day of the study.

Group Type EXPERIMENTAL

Control first Instrument Assisted Soft Tissue Mobilization second

Intervention Type OTHER

This intervention involved waiting for 20 minutes between pre-test and post-test on day one and having Instrument Assisted Soft Tissue Mobilization on day two.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Instrument Assisted Soft Tissue Mobilization first Control second

Instrument assisted soft tissue mobilization was utilized first on day one and wait-control was completed on second day.

Intervention Type OTHER

Control first Instrument Assisted Soft Tissue Mobilization second

This intervention involved waiting for 20 minutes between pre-test and post-test on day one and having Instrument Assisted Soft Tissue Mobilization on day two.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals from a small regional university student body, faculty and staff may choose to volunteer to participate in this study.

Exclusion Criteria

* Acute spinal cord injury with neurological deficits
* Neurological disorders
* Acute lower extremity injury such as sprain or strain
* Acute lower extremity pain causing gait deviation
* Any type of lower extremity fracture within the past 12 months
* Lumbar disc pathology with radicular symptoms
* Use of blood thinning or clotting medications
* Known connective tissue disorder
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minot State University

OTHER

Sponsor Role collaborator

Beth Marschner

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Beth Marschner

Assistant Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Beth Marschner, DPT

Role: PRINCIPAL_INVESTIGATOR

Minot State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Minot State University

Minot, North Dakota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2428

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.